Multicenter, Double-Blind Study of the Efficacy of Injections With Botulinum Toxin Type A Reconstituted Up to Six Consecutive Weeks Before Application
- 1 May 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 29 (5) , 523-529
- https://doi.org/10.1046/j.1524-4725.2003.29121.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- TWO-PLANE INJECTION OF BOTULINUM TOXIN FOR THE TREATMENT OF GLABELLAR FROWN LINESPlastic and Reconstructive Surgery, 2002
- Pain Associated With Injection of Botulinum A Exotoxin Reconstituted Using Isotonic Sodium Chloride With and Without PreservativeArchives of Dermatology, 2002
- Complications and adverse reactions with the use of botulinum toxinSeminars in Cutaneous Medicine and Surgery, 2001
- Botox in dermatologyInternational Journal of Dermatology, 2001
- Botulinum A exotoxin in cosmetic dermatologyClinical and Experimental Dermatology, 2000
- The cosmetic uses of Botulinum toxin type AInternational Journal of Dermatology, 1999
- Botox for Rejuvenation of the Periorbital RegionFacial Plastic Surgery, 1999
- Reconstituted Botulinum Toxin Type A Does Not Lose Potency in Humans If It Is Refrozen or Refrigerated for 2 Weeks Before UseNeurology, 1997
- Crystalline Preparation of Botulinum Toxin Type a (Botox): Degradation in Potency with StorageOtolaryngology -- Head and Neck Surgery, 1993
- Treatment of Glabellar Frown Lines with C. Botulinum‐A ExotoxinThe Journal of Dermatologic Surgery and Oncology, 1992